Home | Contact | Site Index | Careers | My Salugen Login  







Newsroom

The Latest News from Salugen Biosciences

The Newsroom is designed to provide you with easy access to news about the company and its products and to electronic documents typically found in an information kit. If you don't find what you are looking for or need more information, please contact us. 

Downloads

Salugen Biosciences Business Overview

Salugen Biosciences Chronic Pain Fact Sheet

 Definition of Addiction by the American Society of Addictive Medicine

 

Social Media

Salugen Biosciences Twitter Feed

Salugen Biosciences Facebook Page

Press Releases

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH ORTHOPAEDIC SPINE SURGEON DR. MICHAEL ESPOSITO
August 29, 2011

SALUGEN BIOSCIENCES WELCOMES THE NEW DEFINITION OF ADDICTION BY THE AMERICAN ACADEMY OF ADDICTIVE MEDICINE
August 17, 2011

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH AMERICAN PAIN INSTITUTE PRESIDENT DR. MIGUEL DOMINGUEZ
August 16, 2011

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH ASF ORTHOPAEDIC MEDICAL GROUP
August 15, 2011

SALUGEN BIOSCIENCES ANNOUNCES P.I.L.L. STUDY RESULTS LINKING GENETIC VARIATIONS TO ELEVATED RISK FOR OPIOID ABUSE AND DEPENDENCE
August 8, 2011

SALUGEN BIOSCIENCES RESPONDS TO THE 2011 NATIONAL DRUG CONTROL STRATEGY
August 2, 2011

SALUGEN BIOSCIENCES ANNOUNCES OFFICE RELOCATION TO LOS ANGELES, CALIFORNIA
August 1, 2011

SALUGEN BIOSCIENCES ANNOUNCES APPOINTMENT OF UCLA PHSYIATRIST AND CLINICAL PROFESSOR DR. MICHAEL SINEL TO ITS MEDICAL ADVISORY BOARD
July 27, 2011

SALUGEN BIOSCIENCES ANNOUNCES CONTRACT WITH WEST OCEAN MEDICAL GROUP
July 26, 2011

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH MEDICAL PRACTICE MANAGEMENT RESOURCES AND OFFICE EXPANSION IN THE INLAND EMPIRE
July 25, 2011

SALUGEN BIOSCIENCES ANNOUNCES THE END OF "TRIAL AND ERROR" PRESCRIBING PAIN MEDICATIONS WITH THE LAUNCH OF ITS DOLORMED PHARMACOGENETICS TESTING
July 21, 2011

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH PROSPICE MEDICAL GROUP
July 20, 2011

SALUGEN BIOSCIENCES ANNOUNCES AGREEMENT WITH FIRST CALL COMPREHENSIVE
July 19, 2011

SALUGEN BIOSCIENCES ANNOUNCES APPOINTMENT OF LEADING ANESTHESIOLOGIST AS CHIEF MEDICAL OFFICER
July 18, 2011

SALUGEN LAUDS STUDY DEMONSTRATING THE NEED FOR BETTER WAYS TO PREDICT PAIN MEDICATION ABUSERS
July 12, 2011

SALUGEN BIOSCIENCES STATEMENT ON THE PASSING OF BETTY FORD

July 11, 2011

SALUGEN BIOSCIENCES WELCOMES NATIONAL ACADEMIES’ REPORT ON U.S. PAIN MANAGEMENT

July 6, 2011

*These statements have not been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.